Lewis H. Titterton Jr. - 15 Dec 2025 Form 4 Insider Report for Anixa Biosciences Inc (ANIX)

Role
Director
Signature
/s/ Lewis H. Titterton, Jr.
Issuer symbol
ANIX
Transactions as of
15 Dec 2025
Net transactions value
+$46,720
Form type
4
Filing time
16 Dec 2025, 08:56:24 UTC
Previous filing
18 Nov 2025
Next filing
06 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Titterton Lewis H jr Director C/O ANIXA BIOSCIENCES, INC., 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, /s/ Lewis H. Titterton, Jr. 16 Dec 2025 0001499254

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIX Common Stock Options Exercise $46,720 +16,000 +1.7% $2.92 969,334 15 Dec 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANIX Employee Stock Option Options Exercise $0 -16,000 -100% $0.000000 0 15 Dec 2025 Common Stock 16,000 $2.92 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Right-To-Buy, pursuant to a stock option grant dated February 18, 2016.